Showing results (1-10 of 249) with videos related to
Sort By:
Pageof 25
Agents and Actions. Supplements|January 1, 1983
Phospholipids, particularly platelet-activating factor (PAF-acether), in experimental bronchoconstrictionB B VargaftigClinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 21, 1999
What can we learn from murine models of asthma?B B VargaftigEuropean Journal of Pharmacology|August 1, 1978
The inhibition of cyclo-oxygenase of rabbit platelets by aspirin is prevented by salicylic acid and by phenanthrolinesB B VargaftigToxicon : Official Journal of the International Society on Toxinology|January 1, 1982
Platelet activation by non-coagulant snake venom componentsB B VargaftigAmerican Journal of Respiratory and Critical Care Medicine|November 14, 1997
Modifications of experimental bronchopulmonary hyperresponsivenessB B VargaftigThe Journal of Pharmacy and Pharmacology|February 1, 1978
Salicylic acid fails to inhibit generation of thromboxane A2 activity in platelets after in vivo administration to the ratB B VargaftigInternational Angiology : a Journal of the International Union of Angiology|April 1, 1988
Biochemical mediators involved in the inflammatory reaction. Protective activity of S 5682B B VargaftigAgents and Actions. Supplements|January 1, 1977
Involvement of mediators in the interaction of platelets and carrageenanB B VargaftigThe Journal of Pharmacy and Pharmacology|April 1, 1977
Carrageenan and thrombin trigger prostaglandin synthetase-independent aggregation of rabbit platelets: inhibition by phospholipase A2 inhibitorsB B VargaftigEuropean Journal of Pharmacology|September 11, 1981
Enhancement by prostacyclin of the contractility of the guinea-pig airways smooth muscleB B Vargaftig, J LefortPageof 25